AbbVie, Genentech and GSK lead new pharma TV brand advertising in Q3 — reportnews2023-10-27T17:58:57+00:00October 27th, 2023|Endpoints News|
CMS to kick off Medicare drug price negotiation listening sessions next weeknews2023-10-27T17:33:42+00:00October 27th, 2023|Endpoints News|
Accenture boosts life sciences marketing in $245M deal for Novo Nordisk’s obesity ad agency ConcentricLifenews2023-10-27T17:13:44+00:00October 27th, 2023|Endpoints News|
AbbVie’s Humira sales drop in line with analyst projections, and pharma takes Imbruvica impairment chargenews2023-10-27T15:28:22+00:00October 27th, 2023|Endpoints News|
Regeneron reports early gene therapy result in one hearing loss patientnews2023-10-27T15:27:50+00:00October 27th, 2023|Endpoints News|
PTC delays FDA submission timeline on PKU treatment by nine monthsnews2023-10-27T15:05:21+00:00October 27th, 2023|Endpoints News|
Otsuka reports positive PhIII centanafadine trials in children and teenagersnews2023-10-27T14:44:00+00:00October 27th, 2023|Endpoints News|
Intas to pay €42M upfront in Henlius deal; Kymera gets $40M milestone; Pluvicto no longer in short supplynews2023-10-27T14:21:40+00:00October 27th, 2023|Endpoints News|
FDA questions off-target edit testing on Vertex and CRISPR’s potential sickle cell gene therapy ahead of adcommnews2023-10-27T13:44:26+00:00October 27th, 2023|Endpoints News|
Sanofi cuts clinical plans for drugs from Denali, Principia and Kymab dealsnews2023-10-27T11:34:55+00:00October 27th, 2023|Endpoints News|
